These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4758947)

  • 1. Stimulation of locomotor activity of genetically obese mice by amphetamine.
    Yen TT; Acton JM
    Experientia; 1973 Oct; 29(10):1297-8. PubMed ID: 4758947
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of scopolamine and d-amphetamine on locomotor activity before and after shock: a diallel analysis in mice.
    Anisman H
    Psychopharmacology (Berl); 1976 Jul; 48(2):165-73. PubMed ID: 826929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Locomotor activity and expression of c-Fos protein in the brain of C57BL and Balb/c mice: effects of D-amphetamine and sydnocarb].
    Novoselov IA; Cherepov AB; Raevskiĭ KS; Anokhin KV
    Eksp Klin Farmakol; 2002; 65(5):18-21. PubMed ID: 12596507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain differences in amphetamine sensitivity in mice. I. A diallel analysis of open field activity.
    Kitahama K; Valatx JL
    Psychopharmacology (Berl); 1979 Nov; 66(2):189-94. PubMed ID: 119262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of thyroidectomy on amphetamine-induced acceleration of locomotor activity in mice.
    Ohashi K; Tadokoro S
    Jpn J Pharmacol; 1976 Oct; 26(5):621-4. PubMed ID: 1003712
    [No Abstract]   [Full Text] [Related]  

  • 7. Central effects of scopolamine and (+)-amphetamine on locomotor activity: interaction with strain and stress variables;
    Anisman H; Cygan D
    Neuropharmacology; 1975 Nov; 14(11):835-40. PubMed ID: 1207879
    [No Abstract]   [Full Text] [Related]  

  • 8. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice.
    Moisset B; Welch BL
    Experientia; 1973 May; 29(5):625-6. PubMed ID: 4730313
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators].
    Novoselov IA; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(6):3-5. PubMed ID: 14743700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motility of mice after amphetamine: effects of strain, aggregation and illumination.
    Davis WM; Babbini M; Pong SF; King WT; White CL
    Pharmacol Biochem Behav; 1974; 2(6):803-9. PubMed ID: 4463375
    [No Abstract]   [Full Text] [Related]  

  • 12. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of amphetamine and related compounds on locomotor activity and metabolic rate in mice.
    Bushnell PJ
    Pharmacol Biochem Behav; 1986 Jul; 25(1):161-70. PubMed ID: 3018791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the behavioral response to d-amphetamine in mice.
    Moisset B
    Psychopharmacology (Berl); 1977 Aug; 53(3):263-7. PubMed ID: 408855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of d- and 1-amphetamine on spontaneous motor activity in mice.
    Maickel RP; Levine RM; Quirce CM
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):711-4. PubMed ID: 4420179
    [No Abstract]   [Full Text] [Related]  

  • 16. Rate-dependent effects of d-amphetamine on locomotor activity in mice: possible relationship to paradoxical amphetamine sedation in minimal brain dysfunction.
    Glick SD; Milloy S
    Eur J Pharmacol; 1973 Nov; 24(2):266-8. PubMed ID: 4797286
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral and endocrine impact of impaired type II glucocorticoid receptor function in a transgenic mouse model.
    Beaulieu S; Rousse I; Gratton A; Barden N; Rochford J
    Ann N Y Acad Sci; 1994 Nov; 746():388-91. PubMed ID: 7825894
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic and ontogenetic variations in locomotor activity following treatment with scopolamine or d-amphetamine.
    Remington G; Anisman H
    Dev Psychobiol; 1976 Nov; 9(6):579-85. PubMed ID: 1001843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory locomotor response habituation: dissociable effects of (+)-amphetamine and (-)-amphetamine [proceedings].
    Bell R; Cooper SJ
    Br J Pharmacol; 1978 Mar; 62(3):399P. PubMed ID: 638329
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
    Stavchansky S; Riffee W; Geary R
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):189-202. PubMed ID: 4023408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.